Dr. Merchant is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1111 Duff Ave
Ames, IA 50010Phone+1 515-239-4401Fax+1 515-239-4791
Education & Training
- University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1999 - 2001
- University of Virginia Medical CenterResidency, Internal Medicine, 1993 - 1996
- University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1993
Certifications & Licensure
- IA State Medical License 1996 - 2025
- WI State Medical License 1999 - 2005
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Start of enrollment: 2009 Jan 21
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsPhase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats.Joseph Merchant, Kendra D. Tutsch, Amy Dresen, Rhoda Z. Arzoomanian, Dona Alberti
Clinical Cancer Research. 2002-07-01 - 33 citationsPilot and safety trial of carboplatin, paclitaxel, and thalidomide in advanced non small-cell lung cancer.Joseph Merchant, KyungMann Kim, Minesh P. Mehta, Gregory H. Ripple, Marilyn L. Larson
Clinical Lung Cancer. 2000-08-01 - 6 citationsPhase I/II Study of Gemcitabine and Exisulind as Second-Line Therapy in Patients with Advanced Non–small Cell Lung CancerTien Hoang, KyungMann Kim, Joseph Merchant, Anne M. Traynor, James McGovern
Journal of Thoracic Oncology. 2006-03-01
Professional Memberships
- Member
External Links
- McFarland Clinichttp://www.mcfarlandclinic.com/locations/ames/#.V2MibEwrJhE
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: